Pfizer will list its COVID-19 treatment Paxlovid at a price of $1,390 per five-day course when it soon hits the commercial market, the drugmaker confirmed to Axios.

Why it matters: Paxlovid’s new listed price, first reported by the Wall Street Journal, will be more than twice the $529 paid by the federal government, which until now has maintained the entire U.S. supply of the key antiviral medication.

  • PP_GIRL_@lemmy.world
    link
    fedilink
    arrow-up
    2
    arrow-down
    11
    ·
    9 months ago

    everyone I dont like is a nazi

    Wrong. Got vaccinated within the first month of vaccines being given to the public and got boosted last week

    • jackie_jormp_jomp
      link
      fedilink
      arrow-up
      6
      ·
      9 months ago

      Why did you use a quote and not use any of his words, or even the gist of what he said? At no point in that comment did he approach saying that